Shopping Cart
- Remove All
- Your shopping cart is currently empty
AChE-IN-72 (Compound 13a) serves as an inhibitor of acetylcholinesterase (AChE) with an IC50 value of 0.59 μM and also inhibits butyrylcholinesterase (BChE) with an IC50 of 5.02 μM. Moreover, this compound exhibits radical scavenging activity, demonstrated by an IC50 of 5.88 μM, and exhibits iron-chelating properties that inhibit the aggregation of Aβ1-42 and the activation of the NLRP3 inflammasome. AChE-IN-72 has shown to ameliorate memory impairments in a Betaine-induced Alzheimers disease (AD) mouse model and possesses blood-brain barrier (BBB) permeability.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | AChE-IN-72 (Compound 13a) serves as an inhibitor of acetylcholinesterase (AChE) with an IC50 value of 0.59 μM and also inhibits butyrylcholinesterase (BChE) with an IC50 of 5.02 μM. Moreover, this compound exhibits radical scavenging activity, demonstrated by an IC50 of 5.88 μM, and exhibits iron-chelating properties that inhibit the aggregation of Aβ1-42 and the activation of the NLRP3 inflammasome. AChE-IN-72 has shown to ameliorate memory impairments in a Betaine-induced Alzheimers disease (AD) mouse model and possesses blood-brain barrier (BBB) permeability. |
Targets&IC50 | BChE:5.02 μM, AChE:0.59 μM |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.